Our data reveal markedly disparate sex contextual effects on K-ras mutant lung cancer development via differential reprogramming of lung onco- and immune- phenotypes, thus providing insights into potential new strategies for personalized (e.g. sex-based) immunotherapy. The gene discussed is KRAS; the disease is lung carcinoma.